Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedDec 31, 2024
DataAggregated Company Financials
Companies20
  • 7D0.2%
  • 3M-19.8%
  • 1Y-8.7%
  • YTD-8.6%

The Healthcare industry is up 1.9% in the last week, with Novo Nordisk up 2.1%. In the past year, the industry is down 7.1%. Looking forward, earnings are forecast to grow by 15% annually.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 31 Dec 2024DKK 3.3tDKK 387.4bDKK 111.3b29.9x29.6x8.5x
Thu, 28 Nov 2024DKK 3.9tDKK 387.3bDKK 111.3b31.3x34.7x10x
Sat, 26 Oct 2024DKK 4.1tDKK 372.2bDKK 107.2b34x37.9x10.9x
Mon, 23 Sep 2024DKK 4.4tDKK 371.9bDKK 107.1b37.4x40.8x11.8x
Wed, 21 Aug 2024DKK 4.6tDKK 370.6bDKK 107.0b36.2x43.4x12.5x
Fri, 19 Jul 2024DKK 4.5tDKK 355.2bDKK 106.2b35.5x42.5x12.7x
Sun, 16 Jun 2024DKK 5.0tDKK 355.3bDKK 106.2b35.5x46.7x14x
Tue, 14 May 2024DKK 4.6tDKK 354.9bDKK 106.0b34.9x43.6x13x
Thu, 11 Apr 2024DKK 4.4tDKK 341.2bDKK 99.6b37.3x44.6x13x
Sat, 09 Mar 2024DKK 4.7tDKK 341.2bDKK 99.6b39.6x46.7x13.6x
Mon, 05 Feb 2024DKK 4.0tDKK 338.6bDKK 98.5b32.7x40.6x11.8x
Wed, 03 Jan 2024DKK 3.6tDKK 320.5bDKK 90.0b33x40.3x11.3x
Fri, 01 Dec 2023DKK 3.6tDKK 320.5bDKK 90.0b33.2x40.2x11.3x
Sun, 29 Oct 2023DKK 3.4tDKK 305.6bDKK 82.3b26.6x41.5x11.2x
Tue, 26 Sep 2023DKK 3.4tDKK 305.5bDKK 82.2b33.2x41x11x
Thu, 24 Aug 2023DKK 3.4tDKK 305.1bDKK 82.1b35.4x42x11.3x
Sat, 22 Jul 2023DKK 3.0tDKK 287.0bDKK 75.4b40.6x40.1x10.6x
Mon, 19 Jun 2023DKK 3.0tDKK 287.1bDKK 75.5b40.5x40.3x10.6x
Wed, 17 May 2023DKK 3.2tDKK 284.8bDKK 74.9b42x42.1x11.1x
Fri, 14 Apr 2023DKK 3.1tDKK 272.5bDKK 68.5b42.7x45x11.3x
Sun, 12 Mar 2023DKK 2.8tDKK 292.6bDKK 69.2b38.2x40.2x9.5x
Tue, 07 Feb 2023DKK 2.7tDKK 286.9bDKK 68.9b38x39.5x9.5x
Thu, 05 Jan 2023DKK 2.7tDKK 276.1bDKK 66.3b38.2x41.3x9.9x
Sat, 03 Dec 2022DKK 2.6tDKK 276.1bDKK 66.3b38.4x39.6x9.5x
Mon, 31 Oct 2022DKK 2.4tDKK 261.2bDKK 62.4b37.4x38.5x9.2x
Wed, 28 Sep 2022DKK 2.2tDKK 261.4bDKK 62.4b33.5x35.1x8.4x
Fri, 26 Aug 2022DKK 2.4tDKK 260.2bDKK 62.5b36.8x39.2x9.4x
Sun, 24 Jul 2022DKK 2.5tDKK 247.8bDKK 59.9b38.6x41.8x10.1x
Tue, 21 Jun 2022DKK 2.2tDKK 247.7bDKK 59.9b34.1x37.3x9x
Thu, 19 May 2022DKK 2.2tDKK 247.9bDKK 59.8b34.2x37.3x9x
Sat, 16 Apr 2022DKK 2.5tDKK 238.0bDKK 59.8b38.6x41.5x10.4x
Mon, 14 Mar 2022DKK 2.1tDKK 238.0bDKK 59.8b36.4x35.9x9x
Wed, 09 Feb 2022DKK 2.1tDKK 235.9bDKK 59.5b37.8x35.1x8.9x
Fri, 07 Jan 2022DKK 2.2tDKK 229.2bDKK 57.8b51.4x38.2x9.6x
Price to Earnings Ratio

38.2x


Total Market Cap: DKK 2.2tTotal Earnings: DKK 57.8bTotal Revenue: DKK 229.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 40.4x20232024
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 30.1x which is lower than its 3-year average PE of 40.4x.
  • The 3-year average PS ratio of 10.7x is higher than the industry's current PS ratio of 8.7x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 24% per year over the last three years.
  • Revenues for these companies have grown 19% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market0.32%
Healthcare0.19%
Healthcare Services8.76%
Healthtech1.91%
Life Sciences0.75%
Pharma0.26%
Biotech0.20%
Medical Equipment-0.54%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 95.4x.
    • Analysts are expecting annual earnings growth of 17.5%, which is higher than its past year's earnings decline of 23.7% per year.
  • Investors are most pessimistic about the Healthcare Services industry, which is trading close to its 3-year average of 20.9x.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 48% over the next 5 years.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 14% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVO B Novo NordiskDKK 624.200.3%
+DKK 7.1b		-10.6%PE29.2x
DEMANT DemantDKK 264.200.9%
+DKK 522.5m		-10.7%PE22.7x
GMAB GenmabDKK 1.49k0.5%
+DKK 476.4m		-30.7%PE20.2x
ALK B ALK-AbellóDKK 159.101.3%
+DKK 442.4m		57.2%PE44.8x
GUBRA GubraDKK 624.001.6%
+DKK 163.1m		399.2%PS45.5x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

AMBU B

DKK 104.00

Ambu

7D

-2.0%

1Y

-1.1%

Is It Too Late To Consider Buying Ambu A/S (CPH:AMBU B)?

Dec 31
Is It Too Late To Consider Buying Ambu A/S (CPH:AMBU B)?

STRAP

DKK 825.10

Strategic Partners

7D

-2.9%

1Y

-38.0%

ALK B

DKK 159.10

ALK-Abelló

7D

1.3%

1Y

57.2%

NOVO B

DKK 624.20

Novo Nordisk

7D

0.3%

1Y

-10.6%

Is Novo Nordisk (CPH:NOVO B) Using Too Much Debt?

Dec 23
Is Novo Nordisk (CPH:NOVO B) Using Too Much Debt?

ZEAL

DKK 715.50

Zealand Pharma

7D

-0.6%

1Y

91.7%

Analysts Just Made A Substantial Upgrade To Their Zealand Pharma A/S (CPH:ZEAL) Forecasts

Dec 22
Analysts Just Made A Substantial Upgrade To Their Zealand Pharma A/S (CPH:ZEAL) Forecasts

VIRO

DKK 10.60

ViroGates

7D

-10.9%

1Y

76.1%

STENO

DKK 1.30

Stenocare

7D

-1.5%

1Y

-48.8%

EMBLA

DKK 35.60

Embla Medical hf

7D

0.8%

1Y

29.7%

Shareholders Should Be Pleased With Embla Medical hf.'s (CPH:EMBLA) Price

Dec 16
Shareholders Should Be Pleased With Embla Medical hf.'s (CPH:EMBLA) Price

DEMANT

DKK 264.20

Demant

7D

0.9%

1Y

-10.7%

An Intrinsic Calculation For Demant A/S (CPH:DEMANT) Suggests It's 45% Undervalued

Dec 16
An Intrinsic Calculation For Demant A/S (CPH:DEMANT) Suggests It's 45% Undervalued

BAVA

DKK 189.35

Bavarian Nordic

7D

0.9%

1Y

6.7%

Getting In Cheap On Bavarian Nordic A/S (CPH:BAVA) Is Unlikely

Dec 14
Getting In Cheap On Bavarian Nordic A/S (CPH:BAVA) Is Unlikely

CHEMM

DKK 486.20

ChemoMetec

7D

-0.3%

1Y

25.3%

What Is ChemoMetec A/S's (CPH:CHEMM) Share Price Doing?

Dec 12
What Is ChemoMetec A/S's (CPH:CHEMM) Share Price Doing?

GMAB

DKK 1,492.50

Genmab

7D

0.5%

1Y

-30.7%

COLO B

DKK 786.20

Coloplast

7D

-0.9%

1Y

1.8%

HLUN B

DKK 41.32

H. Lundbeck

7D

-0.8%

1Y

26.1%

NNIT

DKK 92.50

NNIT

7D

1.9%

1Y

10.0%

GUBRA

DKK 624.00

Gubra

7D

1.6%

1Y

399.2%